Brought to you by 
Eos and Galapagos build libraries and swap technologies
13 Jul 1999
Executive Summary
Eos Biotechnology Inc. has agreed to provide Galapagos Genomics NV with its oligonucleotide sequences while Galapagos will provide Eos its bio-array technology to validate targets and to build libraries.
Deal Industry
- Biotechnology
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- Product or Technology Swap
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Eos and Galapagos build libraries and swap technologies
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice